Free Trial

SS Innovations International (NASDAQ:SSII) Shares Gap Down - Should You Sell?

SS Innovations International logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • SSII shares declined: The stock opened at $2.58 versus a prior close of $2.70 and was last trading near $2.5950 on relatively light volume.
  • Analyst sentiment remains negative: SSII has a consensus “Sell” rating, although Wall Street Zen recently upgraded it to “Hold”; the average price target is $7.00.
  • Financial performance is weak: The company reported a quarterly loss of $0.01 per share, a negative net margin of 23.73%, and negative return on equity of 26.77%; its CEO also sold 33,333 shares.
  • MarketBeat previews top five stocks to own in November.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) shares gapped down before the market opened on Friday. The stock had previously closed at $2.70, but opened at $2.58. SS Innovations International shares last traded at $2.5950, with a volume of 424 shares changing hands.

Wall Street Analysts Forecast Growth

SSII has been the subject of a number of research reports. Wall Street Zen upgraded SS Innovations International from a "sell" rating to a "hold" rating in a research report on Sunday, June 28th. Weiss Ratings restated a "sell (e+)" rating on shares of SS Innovations International in a research report on Thursday. One research analyst has rated the stock with a Sell rating. According to data from MarketBeat, the stock presently has a consensus rating of "Sell" and an average price target of $7.00.

Read Our Latest Analysis on SSII

SS Innovations International Stock Performance

The business's fifty day moving average price is $3.24 and its two-hundred day moving average price is $3.73. The stock has a market capitalization of $517.98 million, a P/E ratio of -43.08 and a beta of -1.79.

SS Innovations International (NASDAQ:SSII - Get Free Report) last announced its earnings results on Thursday, August 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. SS Innovations International had a negative net margin of 23.73% and a negative return on equity of 26.77%. The business had revenue of $13.94 million for the quarter.

Insiders Place Their Bets

In other SS Innovations International news, CEO Srivastava Sudhir sold 33,333 shares of the business's stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $3.00, for a total transaction of $99,999.00. Following the sale, the chief executive officer directly owned 108,520,928 shares of the company's stock, valued at $325,562,784. The trade was a 0.03% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Institutional Investors Weigh In On SS Innovations International

Several institutional investors have recently modified their holdings of SSII. Eversept Partners LP bought a new position in shares of SS Innovations International during the 4th quarter valued at approximately $428,000. Inspire Investing LLC raised its holdings in SS Innovations International by 26.4% during the 1st quarter. Inspire Investing LLC now owns 104,624 shares of the company's stock valued at $523,000 after buying an additional 21,851 shares during the period. Finally, IFC & Insurance Marketing Inc. raised its holdings in SS Innovations International by 47.7% during the 1st quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company's stock valued at $84,000 after buying an additional 5,400 shares during the period.

About SS Innovations International

(Get Free Report)

SS Innovations International Inc is a medical technology company focused on developing and commercializing robotic-assisted surgical systems. Its principal platform, the SSI MANTRA surgical robotic system, is designed to support minimally invasive procedures by providing surgeons with enhanced visualization, precision and instrument control.

The company also develops related surgical instruments, accessories and technologies intended for use across a range of specialties. Its products are aimed at hospitals and surgical teams seeking robotic assistance for procedures while supporting operating-room efficiency and improved patient care.

SS Innovations was founded by Dr.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SS Innovations International Right Now?

Before you consider SS Innovations International, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SS Innovations International wasn't on the list.

While SS Innovations International currently has a Sell rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Blue-Chip Stocks to Add To Your Forever Portfolio Cover

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines